tm logo
JETEMA THE TOXIN
Live/Registered
REGISTERED

on 11 Aug 2020

Last Applicant/ Owned by

Jijeong-myeon, Wonju-si Gangwon-do

KR

Serial Number

79260523 filed on 30th Apr 2019

Registration Number

6121081 registered on 11th Aug 2020

in the Principal Register

Correspondent Address

Kisuk Lee

Kisuk Lee

7700 BONHOMME AVE, SUITE 400

ST. LOUIS, MO 63105

Filing Basis

No Filing Basis

Disclaimer

NO DATA

JETEMA THE TOXIN

pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceut Read More

Classification Information


Class [005]
Pharmaceutical Products


pharmaceutical agents affecting sensory organs; pharmaceutical agents affecting metabolism; pharmaceutical agents affecting peripheral nervous system; pharmaceutical preparations for urogenital organs; anti-inflammatory and antipyretic preparations; pharmaceutical agents affecting digestive organs; cardiovascular pharmaceutical preparations; ophthalmic preparations; allergy medications; pharmaceutical agents for epidermis; pharmaceutical preparations acting on the central nervous system; analgesics; pharmaceutical preparations for respiratory organs; medicines for dental purposes; Pharmaceutical preparations used in connection with anti-aging, namely, for use in the treatment of glabellar lines, facial wrinkles, asymmetries and defects and conditions of the human skin, and for facial aesthetic surgery, facial aesthetic reconstruction; Pharmaceutical preparations for the treatment of neurological disorders, muscle dystonias, smooth muscle disorders, autonomic nerve disorders, headaches, hyperhydrosis, sports injuries, cerebral palsy, spasms, tremors and pain; Pharmaceutical preparations for the treatment and prevention of urinary incontinence and overactive bladder; Pharmaceutical preparations for the treatment and prevention of osteoporosis; Pharmaceutical preparations and medicines for the treatment and prevention of sexual dysfunction; Pharmaceutical preparations and medicines for the treatment of sensory organ disorders; Pharmaceutical preparations and medicines for the treatment of central nervous system disorders; Pharmaceutical preparations and medicines for the treatment of urogenital organ disorders; Pharmaceutical preparations and medicines for the treatment of circulatory system disorders; Pharmaceutical preparations and medicines for the treatment of cardiovascular and blood pressure; Pharmaceutical preparations for the treatment and prevention of digestive tract, gastrointestinal and dermatological diseases and disorders; Pharmaceutical preparations and medicines for the treatment and prevention of irritable bowel syndrome; Pharmaceutical preparations that support, encourage or promote bone strength or bone health or which are used in the treatment of bone disorders or bone diseases; Pharmaceutical preparations for the prevention and treatment of pain and neuropathic pain; Pharmaceutical preparations for the prevention and treatment of respiratory system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurological diseases and disorders; Pharmaceutical preparations for the prevention and treatment of neurodegenerative diseases and disorders; Pharmaceutical preparations for the prevention and treatment of peripheral nervous system diseases and disorders; Pharmaceutical preparations for the prevention and treatment of hypertension; Pharmaceutical preparations for the prevention and treatment of Alzheimer's disease, dementia, AIDS-related dementia, CNS, neurological disorders, neurodegenerative disorders, and depression; neuroprotective agent; antidepressants; pharmaceuticals, namely, antipsychotics; coronary vasodilating agents; Pharmaceutical preparations for the treatment of hypothyroidism

Mark Details


Serial Number

No 79260523

Mark Type

No Service/Collective Mark

Attorney Docket Number

No 15138-200139

44D Filed

No

44D Current

No

44E filed

No

44E Current

No

66A Filed

No

66A Current

No

Current Basis

No

No Basis

No

Legal History


Show more

Status DateAction Taken
19th Dec 2020FINAL DECISION TRANSACTION PROCESSED BY IB
01st Dec 2020FINAL DISPOSITION NOTICE SENT TO IB
01st Dec 2020FINAL DISPOSITION PROCESSED
11th Nov 2020FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB
11th Aug 2020REGISTERED-PRINCIPAL REGISTER
29th May 2020NOTIFICATION PROCESSED BY IB
26th May 2020PUBLISHED FOR OPPOSITION
26th May 2020OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED
13th May 2020NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB
13th May 2020NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB